Fosun International Limited

HONG KONG, May 27, 2026 /PRNewswire/ -- On 27 May 2026, Fortune China magazine released its 2026 list of "Most Admired Chinese Companies", in which Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was included in the Industry Star List. This highlights Fosun's outstanding performance and industry leadership in environmental, social, and corporate governance (ESG), employee responsibility, and value creation for stakeholders.

In addition to Fosun International, other companies on the list include Industrial and Commercial Bank of China, Bank of China, Tencent Holdings, Alibaba, BYD, China Mobile, Lenovo Group, State Grid Corporation of China, and others.

Driven by Innovation, Committed to Social Contribution, Maintaining Leadership in ESG Performance

Building on years of consistent ESG efforts, Fosun International was once again included this year in the S&P Global Sustainability Yearbook 2026 and, for the third consecutive year, ranked among the top 1% in the S&P Global Sustainability Yearbook (China Edition) 2026. Under the latest MSCI 5.0 rating model, Fosun International's MSCI ESG rating has been upgraded to the highest rating AAA; its Hang Seng Sustainability Rating has remained at AA-; its FTSE Russell ESG score has risen to 4.2 (maximum score: 5); and Fosun International has been selected as a constituent of the FTSE4Good Index Series for the fifth consecutive year. The continued improvement across multiple international ratings and indices reflects Fosun's long-term commitment and solid progress in ESG governance, information disclosure, risk management, and sustainable development practices.

Fosun integrates innovation-driven development with social responsibility, charting a sustainable path guided by technology innovation and accountability. Its Health business segment remains committed to bringing hope of cure to more patients by addressing unmet clinical needs. It has established a deep presence in core therapeutic areas such as oncology, immunology and inflammation, and neurodegenerative diseases, while actively expanding into cardiometabolic diseases and rare diseases. This approach enables the development of high valued competitive pipelines and comprehensive healthcare solutions. Meanwhile, it continues to consolidate its core technical platforms including but not limited to antibodies and antibody-drug conjugates (ADCs), small molecules and cell therapies. Additionally, it actively advances cutting-edge therapeutic modalities such as radiopharmaceuticals and small nucleic acids.

In the field of rare diseases, taking FUMAINING as an example, in 2025, the Class 1 new drug luvometinib tablets (FUMAINING) independently developed by Fosun Pharma was approved for two indications in Chinese mainland. The approved indications are for the treatment of Langerhans Cell Histiocytosis (LCH) and Neurofibromatosis Type 1 with Plexiform Neurofibromas (NF1-PN), filling the gap in the treatment of rare tumor diseases in Chinese mainland.

The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago, United States from 29 May to 2 June. Data from a Phase III study of luvometinib tablets (FUMAINING) in adult patients with symptomatic, inoperable PN associated with NF1 has been successfully selected for a Rapid Oral Presentation, providing a new, efficient treatment option for adult patients with NF1-PN.

Furthermore, Henlius' HLX43, a potential best-in-class broad-spectrum anti-tumor PD-L1 ADC, will have its key subgroup progression-free survival (PFS) data in non-small cell lung cancer (NSCLC) presented for the first time in a Rapid Oral Presentation at ASCO, further supporting its clinical potential and value in the later-line treatment of refractory NSCLC. Currently, international multicenter clinical trials for NSCLC are rapidly advancing across China, Europe, the United States, Australia, Japan, and other regions. Beyond NSCLC, HLX43 has demonstrated significant advantages characterized by favorable efficacy and safety profile, along with encouraging signals in gynecological tumors, esophageal squamous cell carcinoma (ESCC), and other solid tumors.

In the field of cell therapy, Fosun Kairos continues to improve the accessibility and affordability of Yi Kai Da (ejilunsai injection), the first CAR-T cell therapy product approved in Chinese mainland. As of the end of 2025, the product had been included in over 110 urban customized commercial health insurances and over 90 commercial insurances, while the number of certified treatment centers on record exceeded 210, covering more than 29 provinces and municipalities across China. In December 2025, it was also included in the first edition of the Commercial Health Insurance Innovative Drugs Catalogue, providing additional payment channels to help ease patients' financial burden and improve access to this advanced therapy.

Regarding global public health, as of the end of 2025, Fosun Pharma's independently developed artesunate for injection had saved more than 88 million severe malaria patients worldwide, with more than 440 million doses supplied globally. The Seasonal Malaria Chemoprevention (SMC) program, centered on the SPAQ-CO product portfolio, had benefited more than 330 million children in Africa. In addition, the main structure of Phase I of the Côte d'Ivoire industrial park in Africa was successfully topped out, and a local manufacturing license was obtained, laying a solid foundation for localized pharmaceutical manufacturing and supply in Africa.

In terms of rural revitalization, as of the end of 2025, the Rural Doctors Program had covered 78 counties in 16 provinces, cities, and autonomous regions (including 25 key counties for national rural revitalization), supported 25,000 rural doctors, and benefited 16.34 million rural residents and 3 million rural families.

Actively responding to climate change and promoting low-carbon transition

In response to climate change and low-carbon transition, Fosun actively responds to the national "dual carbon" goals by promoting carbon neutrality and energy conservation and emissions reduction. In 2021, Fosun made a commitment to society – "strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050". Fosun has formulated strategies for climate change mitigation and adaptation to align with the 1.5°C temperature control target set in the Paris Agreement. Building on its commitment to achieve carbon neutrality by 2050, Fosun has set a mid-term target to reduce the intensity of Scope 1 and Scope 2 GHG emissions by 20% by 2034, using 2024 as the base year. This reflects Fosun's rigorous management of operational emissions and demonstrates the Group's commitment and execution in advancing low-carbon transition.

The Group actively encourages its member companies to carry out climate actions. In 2025, 97% of Club Med's eligible resorts had passed the audit and obtained the Green Globe Certification, the world's leading certification for sustainable tourism. Besides, Atlantis Sanya, Taicang Alps Resort and Lijiang Club Med Resort had obtained LEED Gold Certification, demonstrating Fosun's ongoing efforts and achievements in green building and sustainable tourism.

Looking ahead, Fosun will continue to deepen its industrial operations, strengthen innovation and globalization, and further enhance its ESG management system. The company will actively respond to national and global sustainability strategies, drive the realization of sustainable development goals, promote technology innovation, implement the "dual carbon" targets, and engage in philanthropic initiatives. Fosun is committed to fostering the long-term sustainable growth of its businesses, creating lasting value for stakeholders, safeguarding employees' rights, and improving customer satisfaction, while steadfastly fulfilling its mission of "Creating happier lives for families worldwide."

View original content:https://www.prnewswire.com/apac/news-releases/fosun-international-recognized-on-fortunes-2026-most-admired-chinese-companies-list-302782962.html

SOURCE Fosun

HONG KONG, May 21, 2026 /PRNewswire/ -- On 21 May 2026, S&P Global hosted the "Sustainability Yearbook (China Edition) 2026 Launch Ceremony and Sustainability Forum" in Shanghai. Fosun International Limited (Hong Kong Stock Exchange stock code: 00656, "Fosun International") was included in the S&P Global Sustainability Yearbook (China Edition) 2026 and ranked among China's Top 1% for the third consecutive year, recognizing its long-standing commitment to advancing environmental, social and governance (ESG) practices. This achievement underscores Fosun International's industry-leading position in sustainability management and ESG efforts.

This year, nearly 1,800 Chinese companies that participated in the 2025 Corporate Sustainability Assessment (CSA) and were eligible for inclusion in the S&P Global Sustainability Yearbook (China Edition) 2026 were evaluated, with only about 190 outstanding companies ultimately selected for inclusion. According to the selection criteria for the S&P Global Sustainability Yearbook 2026, companies included in the Yearbook must achieve a CSA score of at least 30 in their respective industries, rank within the top 15% of their industry, and have a score within 30% of the industry's top-performing company. To be recognized as among the "Top 1%", companies must achieve a CSA score of at least 60 and have a score within 1% of the highest score in their industry.

With years of sustained investment in ESG, Fosun International has consistently enhanced its S&P Global CSA score and maintained a leading position among its peers. In the 2025 S&P Global CSA, the company achieved an outstanding score of 73. As of May 2026, Fosun International ranked in the top 7% among its global industry peers in the assessed industry, outperforming the industry average by nearly 40 points. This achievement demonstrates Fosun International's balanced progress across the environmental, social, governance, and economic dimensions.

In addition, in February 2026, Fosun International was also included in the S&P Global Sustainability Yearbook 2026. The assessment universe covered more than 9,200 companies in the 2025 CSA, of which only 848 companies were ultimately selected, demonstrating that Fosun International's ESG management performance continues to be recognised by authoritative international institutions.

In recent years, Fosun International has delivered strong results in global ESG ratings. Under the latest MSCI 5.0 rating model, Fosun International's MSCI ESG rating has been upgraded to AAA; its Hang Seng Sustainability Rating has remained at AA-; its FTSE Russell ESG score has risen to 4.2; and Fosun International has been selected as a constituent of the FTSE4Good Index Series for the fifth consecutive year. The continued improvement across multiple international ratings and indices reflects Fosun's long-term commitment and solid progress in ESG governance, information disclosure, risk management, and sustainable development practices.

As an industry group rooted in China with a global presence, Fosun has consistently placed sustainable development at the core of its long-term corporate strategy. In 2025, Fosun continued to advance its "Create IMPACT" sustainability strategy, focusing on six key directions: Innovation-driven, Mindful Operation, People and Partner Oriented, Advanced Governance, Climate and Planet Positive, and Transparency. The Group further integrated ESG principles into corporate governance, industrial operations, risk management, and global development. Meanwhile, Fosun has established a comprehensive ESG governance structure comprising the Board, the ESG Board Committee, and a multi-level management mechanism, continuously enhancing systematic management, transparency, and execution of its sustainability efforts, while empowering resilient business growth through high-quality ESG practices.

In addressing climate change, Fosun actively responds to China's "dual carbon" goals and continues to advance its low-carbon transition. In April 2026, Fosun released its fourth Climate Information Disclosures Report. In line with the full implementation of the Hong Kong Stock Exchange's new climate requirements, Fosun further aligned with leading international climate disclosure frameworks, referencing the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations and the International Financial Reporting Standards S2 Climate-related Disclosures Requirements (IFRS S2). These efforts continuously enhance the transparency of Fosun's climate actions and strengthen its climate risk management capabilities.

Fosun has made a commitment to "strive to achieve carbon emissions peak by 2028 and carbon neutrality by 2050". Building on this commitment, Fosun has set a mid-term target to reduce the intensity of Scope 1 and Scope 2 GHG emissions by 20% by 2034, using 2024 as the base year. At the same time, Fosun continues to advance the long-term sustainable development of the Group and its industrial ecosystem through initiatives such as green buildings, sustainable tourism, green finance, energy conservation and emissions reduction, and climate actions undertaken by its member companies.

Looking ahead, Fosun will continue to deepen its industrial operations, strengthen innovation and globalisation, continuously improve its ESG management system, actively respond to national and global sustainability strategies, safeguard information security, promote technology innovation, implement the "dual carbon" goals, engage in philanthropic initiatives, protect employees' rights and interests, and promote the long-term sustainable development of its business. Fosun is committed to creating lasting value for all stakeholders and to firmly fulfilling its mission of "Creating happier lives for families worldwide".

View original content:https://www.prnewswire.com/apac/news-releases/fosun-international-included-in-sp-global-sustainability-yearbook-china-edition-2026-maintains-top-1-ranking-for-third-consecutive-year-302778792.html

SOURCE Fosun